After June 30, 2025, CPBC will not accept any new applications for registration as a temporary pharmacist, temporary limited pharmacist, temporary student pharmacist, or temporary pharmacy technician.
CPBC is sharing Health Canada's position statement below to ensure all registrants are aware of Health Canada's directive regarding GLP-1 compounding activities.
This guest post highlights an important interaction between antiretroviral medications and intranasal corticosteroids. Pharmacists must be aware of these interactions when prescribing for minor ailments, providing therapeutic substitutions, and providing over-the-counter recommendations to patients. For support in managing drug interactions with antiretrovirals, pharmacists can call St. Paul’s...
An estimated 4 million Canadians are affected by chronic kidney disease (CKD).1 Patients with chronic kidney disease (CKD) are on a median of 8 drugs and are at high risk of experiencing adverse drug reactions (ADRs)
Effective immediately, all prescribed alternative (PA) doses dispensed must be accompanied by either the intervention code “VS – Other outcome or intervention” for witnessed PA or the intervention code “SA – Prescribed safer alternative” for non-witnessed PA.
JOB OPPORTUNITY: Administrative Assistant – Registration & Licensure
CPBC is currently recruiting for an Administrative Assistant – Registration & Licensure.
View the Full Job Posting: |
Every June, during National Indigenous History Month in Canada, we honour the stories, achievements and resilience of First Nations, Inuit, and Métis Peoples across Canada, both now and throughout history. It's a time for us...
JOB OPPORTUNITY: Senior Business Analyst
CPBC is currently recruiting for a Senior Business Analyst.
View the Full Job Posting: |